Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yoshinori Yanai"'
Autor:
Yoshinori Yanai, Takeo Kosaka, Shuji Mikami, Hiroshi Hongo, Yota Yasumizu, Toshikazu Takeda, Kazuhiro Matsumoto, Jun Miyauchi, Shigehisa Kitano, Mototsugu Oya
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract To stratify the heterogeneity of prostate cancer (PCa) with seminal vesicle invasion (SVI) immunologically after radical prostatectomy focusing on the tumor microenvironment. We retrospectively reviewed the clinicopathological data of 71 PCa
Externí odkaz:
https://doaj.org/article/d4d29165ddca4fb0be5007d5086791f2
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-4 (2019)
Abstract Background Interstitial pneumonitis is a rare reaction in a previously irradiated area of pulmonary or thoracic lesion after treatment with anticancer drugs such as taxanes. Case presentation A 66-year-old man presented with a fever and dysp
Externí odkaz:
https://doaj.org/article/c0df56211c2042518f95521527b792ca
Publikováno v:
IJU Case Reports, Vol 2, Iss 4, Pp 187-189 (2019)
Introduction Abiraterone acetate in combination with prednisone is now widely used for the treatment of castration‐resistant prostate cancer. Case presentation A 62‐year‐old patient with a bone metastatic castration‐resistant prostate cancer
Externí odkaz:
https://doaj.org/article/9061c1f161764990ab8bb7093bdb606b
Autor:
Takeo Kosaka, Toshikazu Takeda, Yota Yasumizu, Kazuhiro Matsumoto, Hiroshi Hongo, Yoshinori Yanai, Mototsugu Oya, Jun Miyauchi, Shuji Mikami, Shigehisa Kitano
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports
Scientific Reports
To stratify the heterogeneity of prostate cancer (PCa) with seminal vesicle invasion (SVI) immunologically after radical prostatectomy focusing on the tumor microenvironment. We retrospectively reviewed the clinicopathological data of 71 PCa patients
Autor:
Takeo Kosaka, Toshikazu Takeda, Mototsugu Oya, Isao Kurihara, Hiroshi Itoh, Shinya Morita, Yota Yasumizu, Hiroshi Asanuma, Nobuyuki Tanaka, Tsukasa Masuda, Ryuichi Mizuno, Kazuhiro Matsumoto, Kyohei Hakozaki, Yoshinori Yanai
Publikováno v:
Clinical Endocrinology. 95:716-726
OBJECTIVE Pheochromocytoma is a rare neuroendocrine tumour that secretes catecholamines and originates in the adrenal gland. Although surgical resection is the only curative therapy for pheochromocytoma, it is associated with a risk of haemodynamic i
Autor:
Yoshinori Yanai, Ryuichi Mizuno, Takeshi Masuda, Mototsugu Oya, Masafumi Oyama, Shintaro Hasegawa, Keisuke Shigeta, Tadatsugu Anno, Kimiharu Takamatsu, Keitaro Watanabe, Eiji Kikuchi, Koichiro Ogihara
Publikováno v:
Japanese Journal of Clinical Oncology. 51:984-991
Background It currently remains unclear whether the location of primary tumours affects the clinical outcomes of patients with locally advanced urothelial carcinoma in the urinary tract. The aim of the present study was to compare prognostic differen
Autor:
Tomohiro Iwasawa, Takeo Kosaka, Yota Yasumizu, Hiroshi Hongo, Yoshinori Yanai, Yuto Baba, Kazuhiro Matsumoto, Kohei Nakamura, Hiroshi Nishihara, Mototsugu Oya
Publikováno v:
International journal of clinical oncology. 27(12)
Background Prostate cancer harboring cyclin-dependent kinase 12 (CDK12) abnormalities is a hot topic due to its distinctive clinical features, such as sensitivity to immune checkpoint inhibitors. In the last few years, precision medicine using compre
Autor:
Eriko Aimono, Kazuhiro Matsumoto, Shinya Morita, Kohei Nakamura, Hiroshi Nishihara, Mototsugu Oya, Shuji Mikami, Yoshinori Yanai, Takeo Kosaka
Publikováno v:
Cancer Science
Cyclin‐dependent kinase 12 (CDK12), one of the key factors associated with DNA damage response pathways, is located on chromosome 17 proximal to Erb‐B2 receptor tyrosine kinase 2 (ERBB2). In this report, CDK12 and ERBB2 coamplification was detect
Autor:
Hiroshi Asanuma, Toshiaki Shinojima, Shinya Morita, Yoshinori Yanai, Kazuhiro Matsumoto, Takeo Kosaka, Toshikazu Takeda, Mototsugu Oya, Nobuyuki Tanaka, Ryuichi Mizuno
Publikováno v:
International Journal of Clinical Oncology. 25:1393-1397
Biochemical recurrence (BCR) after radical prostatectomy (RP) is most commonly diagnosed by detecting an increase in asymptomatic prostate-specific antigen (PSA). We previously reported the “optimal PSA follow-up schedule after RP”. The aim of th
Autor:
Hiroshi Asanuma, Nobuyuki Tanaka, Kazuhiro Matsumoto, Akari Komatsuda, Takeo Kosaka, Toshikazu Takeda, Shinya Morita, Mototsugu Oya, Ryuichi Mizuno, Yoshinori Yanai, Toshiaki Shinojima
Publikováno v:
Asian Journal of Endoscopic Surgery. 13:526-531
INTRODUCTION The goal of partial nephrectomy for renal tumors is complete tumor removal with the preservation of renal function and no complications. Trifecta (total ischemia time